Font Size: a A A
Keyword [large B-Cell]
Result: 181 - 200 | Page: 10 of 10
181. The Study Of B7-H1/PD-1Pathway In Diffuse Large B Cell Lymphoma
182. To Study The MicroRNA Expression Profilesinfor AIDS Related Diffuse Large B-cell Lymphoma
183. Study On C-MYC Protein Expression And Its Significance In Diffuse Large B Cell Liyphoma
184. Expression Of HIP1R And FOXP1 In Diffuse Large B-Cell Lymphoma And Its Relationship With Prognosis
185. Analysis Of Predicting Efficiency Of NCCN-IPI In Patients With Diffuse Large B-Cell Lymphoma
186. CD 10, BCL-6, MUM-1 And BCL-2 Expression In Diffuse Large B Cell Lymphoma And Its Relationship With Prognosis
187. To Investigate The MicroRNA Expression Profile In Diffuse Large B-cell Lymphoma
188. Prognostic Factors Analysis Of 59 Patients With Diffuse Large B-cell Lymphoma
189. A Case Report Of Primary Gastric Malignant Lymphoma And Literature Review
190. Expression And Function Of MicroRNA-29b In Diffuse Large B-cell Lumphoma
191. Expression And Significance Of IL-12 In Classical Hodgkin Lymphoma And Diffuse Large B-cell Lymphoma
192. Expression Of Has-miR-339-3p And Has-miR-339-5p In Diffuse Large B_cell Lymphoma And Its Significance
193. Clinical Pathological Features And Analysis Of 179 Caseswith Diffuse Large B Cell Lymphoma(DLBCL)
194. Clinical Study Of Young Patients With High Risk Diffuse Large B-Cell Lymphoma(DLBCL)
195. The Value Of 18F-FDG PET/CT In Different Phase Of Chemotherapy For Predicting The Prognosis Of Non-Hodgkin Lymphoma
196. Clinical And Pathological Characteristics Of De Novo DLBCLs With Decreased CD20 Cell Surface Expression
197. Structure Aberration Of MYC Gene And Regulation Of MYC Protein By BCR Signaling In Diffuse Large B-cell Lymphoma
198. Loss Of IRF8 Inhibits The Growth Of Diffuse Large B-cell Lymphoma
199. Efficacy Analysis On Rituximab Combined With Chemotherapy In The Treatment Of Diffuse Large B-cell Lymphoma And Bcl-2 Protein Overexpression
200. Inhibition Of Indoleamine 2, 3-Dioxygenase In CD20+ Diffuse Large B Cell Lymphoma Cell Correlates With Rituximab-mediated Antibody-dependent Cell-mediated Cytotoxicity
  <<First  <Prev  Next>  Last>>  Jump to